![David Bejker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Bejker
Directeur/Membre du Conseil chez
ABLIVA AB
Profil
David Bejker is currently Chief Executive Officer at Affibody Medical AB since 2018.
He is an Independent Director at Abliva AB since 2017.
He is also a Director at Amylonix AB and Disruptive Pharma Holding AB. Formerly, Mr. Bejker was Chief Executive Officer & Director at Affibody AB from 2003 to 2005.
Other former roles include Deputy Director at Nexstim Oyj, Independent Director at LIDDS AB, and Principal at HealthCap AB. Education includes graduate studies at Stockholm School of Economics.
Postes actifs de David Bejker
| Sociétés | Poste | Début |
|---|---|---|
| ABLIVA AB | Directeur/Membre du Conseil | 27/04/2017 |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Directeur Général | 01/12/2018 |
Amylonix AB
 Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Directeur/Membre du Conseil | - |
Disruptive Pharma Holding AB | Directeur/Membre du Conseil | - |
Anciens postes connus de David Bejker
| Sociétés | Poste | Fin |
|---|---|---|
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Directeur Général | 01/07/2005 |
| LIDDS AB | Directeur/Membre du Conseil | - |
| NEXSTIM PLC | Corporate Officer/Principal | - |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Formation de David Bejker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Abliva AB
 Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Health Technology |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nexstim Oyj
 Nexstim Oyj Medical SpecialtiesHealth Technology Develops non-invasive brain stimulation technology | Health Technology |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Amylonix AB
Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Health Technology |
Disruptive Pharma Holding AB |
